Foehr David sold $224K of CBLL
Foehr David (Senior VP, Finance and PAO) sold 9,255 shares of Ceribell, Inc. (CBLL) at an average of $24.25 ($24.25–$24.26, $0.22M total) across 2 trades on 2026-09-08 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data for short-term traders but is unlikely to move the stock significantly.
Market read
Primary insider sale; modest size; limited trading relevance.
What to watch
The insider retains a sizable holding of 34,144 shares, indicating continued confidence.
Background
Form 4 filings disclose insider transactions; a 10b5-1 plan sale is pre-arranged and may not reflect current sentiment.
Ticker impact
Senior VP of Finance sold 9,255 shares for $224K via a 10b5-1 plan on Sep 8, 2026.
Modest downward pressure over the next few days.
The sale size is modest relative to float, but insider status and use of a 10b5-1 plan suggest a neutral to slightly negative impact.
Market effects
Minimal impact on the medical device sector.
No significant regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale could be routine portfolio rebalancing, not a negative signal.
Key entities
- CompanyCeribell, Inc.
Medical device company specializing in neuro-monitoring.
- InsiderDavid Foehr
Senior Vice President, Finance and PAO at Ceribell.